Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-117382
Filing Date
2025-12-01
Accepted
2025-12-01 17:15:43
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tm2532031d1_424b5.htm 424B5 442856
2 GRAPHIC tm2532031d1_424b5img01.jpg GRAPHIC 4899
3 GRAPHIC tm2532031d1_424b5img02.jpg GRAPHIC 14458
4 GRAPHIC tm2532031d1_424b5img03.jpg GRAPHIC 17962
5 GRAPHIC tm2532031d1_424b5img04.jpg GRAPHIC 28537
  Complete submission text file 0001104659-25-117382.txt   535422
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-289585 | Film No.: 251540696
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)